Scienza e Tecnologia
SOPHiA GENETICS Achieves CE-IVD Certification using its SOPHiA DDM™ Platform
"We started SOPHiA GENETICS with a mission to be the global platform that allows healthcare professionals to leverage their expertise and work together around the world – unlocking the promise of data-driven medicine at scale," said Dr. Jurgi Camblong, co-founder and CEO at SOPHiA GENETICS. "The CE-IVD certification for these IVD applications is a milestone that reflects the quality and reliability of our SOPHiA DDM™ Platform. This will help us meet the needs of our healthcare partners in the EU who want to implement SOPHiA GENETICS' proprietary algorithms for clinical use."
Supporting the CE-IVD certifications using the SOPHiA DDM™ Platform demonstrates the commitment of SOPHiA GENETICS in maintaining a firm focus on delivering accurate and reliable solutions to more than 790 leading healthcare institutions across the world. The SOPHiA DDM™ Platform, leverages on the collective intelligence gathered by SOPHiA GENETICS' global network of connected partners. Healthcare professionals can confidently adopt standardized data-driven medicine applications as part of their routine workflow in the EU, for the benefit of patients all over the world.
SOPHiA GENETICS (Nasdaq: SOPH) is a health care technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM™ Platform, a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The SOPHiA DDM™ Platform and related solutions, products and services are currently used by more than 790 hospital, laboratory, and biopharma institutions globally. For more information, visit SOPHiAGENETICS.COM , or connect on Twitter , LinkedIn and Instagram .
Logo - https://mma.prnewswire.com/media/1673202/SOPHiA_GENETICS_Logo.jpg